Prasugrel and Ticagrelor in ST-segment Elevation Myocardial Infarction
Status:
Terminated
Trial end date:
2015-04-01
Target enrollment:
Participant gender:
Summary
To compare efficacy and safety of prasugrel and ticagrelor in patients with ST-segment
elevation myocardial infarction undergoing primary percutaneous coronary intervention.